Implementation of sodium-glucose co-transporter 2 inhibitors use in patients with heart failure across the ejection fraction: data from the Swedish heart failure registry
{{output}}
Aims: To assess the implementation of sodium-glucose co-transporter-2 inhibitors (SGLT2i) use in a real-world heart failure (HF) cohort. Methods and results: ... ...
